Lexicon Pharmaceuticals (LXRX) EBT Margin (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly EBT Margin of 25.1% for Q1 2026, up 224487.0% year-over-year from N/an in Q1 2025, and up 91.8% quarter-over-quarter from 306.04% in Q4 2025.
Lexicon Pharmaceuticals (LXRX) EBT Margin (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported EBT Margin for 16 consecutive years, with 25.1% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 224487.0% year-over-year to 25.1%; the TTM figure through Mar 2026 stood at 61.69% (up 55043.0% YoY), while the FY2025 annual figure was 121.59%, up 186692.0% from the prior year.
- EBT Margin climbed to 25.1% in Q1 2026 per LXRX's latest filing, from 306.04% in the prior quarter.
- Across five years, EBT Margin topped out at 14.45% in Q2 2025 and bottomed at 74708.57% in Q2 2022.
- Historically, EBT Margin has averaged 11628.42% across 5 years, with a median of 3495.14% in 2024.
- Annual changes were most pronounced in 2023 — EBT Margin soared 5705324 bps — and 2025, when it plunged 16823 bps.
- Lexicon Pharmaceuticals' EBT Margin stood at 74708.57% in 2022, then jumped by 91 bps to 6928.33% in 2023, then jumped by 98 bps to 137.81% in 2024, then slumped by 122 bps to 306.04% in 2025, then jumped by 92 bps to 25.1% in 2026.
- Business Quant data shows LXRX's EBT Margin at 25.1% in Q1 2026, 306.04% in Q4 2025, and 117.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | -5,394.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,394.65% |
| Mar 31, 2026 | -25.10% |
| Dec 31, 2025 | -306.04% |
| Sep 30, 2025 | -117.66% |
| Jun 30, 2025 | -14.45% |
| Mar 31, 2025 | -2,269.97% |
| Dec 31, 2024 | -137.81% |
| Sep 30, 2024 | -3,900.29% |
| Jun 30, 2024 | -3,495.14% |
| Mar 31, 2024 | -4,600.27% |
| Dec 31, 2023 | -6,928.33% |
| Sep 30, 2023 | -37,010.49% |
| Jun 30, 2023 | -17,655.33% |
| Jun 30, 2022 | -74,708.57% |
| Dec 31, 2020 | -2,761.31% |
| Jun 30, 2020 | -281,008.00% |
| Mar 31, 2020 | -835.02% |
| Dec 31, 2019 | -585.97% |
| Sep 30, 2019 | 76.97% |
| Jun 30, 2019 | -2,750.70% |